Home LiteratureArticle Details
PMID: 18761218 Published · ppublish English Comment Letter

Intensive insulin therapy in patients with type 2 diabetes.

Lancet (London, England) ·Vol. 372 ·No. 9640 ·2008-08-30 ·Pages 716-7; author reply 717-8

Bering B, Devendra D

Abstract

暂无摘要

MeSH Terms
Diabetes Mellitus, Type 1/drug therapy,immunology Diabetes Mellitus, Type 2/drug therapy Glutamate Decarboxylase/immunology Humans Hypoglycemic Agents/administration & dosage Insulin/administration & dosage
Chemicals
Hypoglycemic Agents Insulin Glutamate Decarboxylase glutamate decarboxylase 2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bering Balpreet
Devendra Devasenan
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
1474-547X
DOI
10.1016/S0140-6736(08)61301-X
Published
2008-08-30
Pages
716-7; author reply 717-8
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 18502299
External Links
PubMed source DOI: 10.1016/S0140-6736(08)61301-X View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2